Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Hopper

Showing results (351-360 of 894) with videos related to

Pageof 90
Sort By:
Clinical Chemistry|April 30, 2014
Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spotsYoshimi Inaba, Charles E Schwartz, Quang M Bui, et al.
Expert Reviews in Molecular Medicine|July 2, 2015
Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysisDavid E Godler, Yoshimi Inaba, Charles E Schwartz, et al.
Cancers|March 25, 2022
Familial Aspects of Mammographic Density Measures Associated with Breast Cancer RiskTuong L Nguyen, Shuai Li, James G Dowty, et al.
JNCI Cancer Spectrum|May 12, 2021
Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk ModelsSherly X Li, Roger L Milne, Tu Nguyen-Dumont, et al.
Journal of the National Cancer Institute|January 24, 2018
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population WomenRanjit Manchanda, Shreeya Patel, Vladimir S Gordeev, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental FactorsYingye Zheng, Xinwei Hua, Aung K Win, et al.
Genes & Cancer|January 26, 2016
Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndromeAung Ko Win, Mark Clendenning, William Crawford, et al.
JAMA Oncology|June 19, 2015
Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family RegistryMatthew B Yurgelun, Serena Masciari, Victoria A Joshi, et al.
Cancers|June 10, 2022
Genetic Aspects of Mammographic Density Measures Associated with Breast Cancer RiskShuai Li, Tuong L Nguyen, Tu Nguyen-Dumont, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Penetrance analysis of the PALB2 c.1592delT founder mutationHannele Erkko, James G Dowty, Jenni Nikkilä, et al.
Pageof 90

Showing results (351-360 of 894) with videos related to

Sort By:
Pageof 90
Clinical Chemistry|April 30, 2014
Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spotsYoshimi Inaba, Charles E Schwartz, Quang M Bui, et al.
Expert Reviews in Molecular Medicine|July 2, 2015
Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysisDavid E Godler, Yoshimi Inaba, Charles E Schwartz, et al.
Cancers|March 25, 2022
Familial Aspects of Mammographic Density Measures Associated with Breast Cancer RiskTuong L Nguyen, Shuai Li, James G Dowty, et al.
JNCI Cancer Spectrum|May 12, 2021
Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk ModelsSherly X Li, Roger L Milne, Tu Nguyen-Dumont, et al.
Journal of the National Cancer Institute|January 24, 2018
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population WomenRanjit Manchanda, Shreeya Patel, Vladimir S Gordeev, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental FactorsYingye Zheng, Xinwei Hua, Aung K Win, et al.
Genes & Cancer|January 26, 2016
Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndromeAung Ko Win, Mark Clendenning, William Crawford, et al.
JAMA Oncology|June 19, 2015
Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family RegistryMatthew B Yurgelun, Serena Masciari, Victoria A Joshi, et al.
Cancers|June 10, 2022
Genetic Aspects of Mammographic Density Measures Associated with Breast Cancer RiskShuai Li, Tuong L Nguyen, Tu Nguyen-Dumont, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Penetrance analysis of the PALB2 c.1592delT founder mutationHannele Erkko, James G Dowty, Jenni Nikkilä, et al.
Pageof 90